Tradestie Institutional Equity Comparison Engine

AVDL vs ALVO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Momentum & Technical, Options & Structure while ALVO counters with relative strength in Valuation, Growth & Margin. Fundamentally, AVDL trades at 28.8x Forward P/E with 2.5% operating margin (+54.9% YoY revenue) versus ALVO at 19.4x Forward P/E and 12.9% operating margin (-2.0% YoY). In options structure, AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against ALVO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ALVO
AVDL 28.8x vs ALVO 19.4x Fwd P/E
Growth & Margin Winner ALVO
Op Margin 2.5% vs 12.9% ยท YoY +54.9% vs -2.0%
Momentum & Technical Winner AVDL
1Y +138.1% vs -21.2% ยท 52W Pos 89% vs 33%
Options & Structure Winner AVDL
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0
ALVO NASDAQ
Alvotech Ordinary Shares
Biological Products, (No Diagnostic Substances)
$4.12
-3.96% 1D
Market Cap $1.5B
1M Return -13.99%
1Y Return -21.22%
Forward P/E 19.4x
Unified AI Score
52.2 / 100 HOLD
Tech 29.0 Fund 46.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AVDL +138.06% ALVO -21.22% Spread: +0.95 pp (AVDL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AVDL TTM Op. Margin: 2.5% ALVO TTM Op. Margin: 12.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVDL vs ALVO. Trailing 12-month operating profitability (AVDL 2.5% vs ALVO 12.9%) and valuation multiples (AVDL 28.8x vs ALVO 19.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AVDL (6) vs ALVO (4)
Institutional Metric AVDL ALVO Criterion Row Winner
Market Capitalization Scale $2.1B $1.5B Larger Scale AVDL
Trailing P/E Ratio Valuation 16.8x 15.2x Lower Multiple ALVO
Forward P/E Ratio Valuation 28.8x 19.4x Lower Multiple ALVO
Revenue Growth (YoY) Growth +54.9% -2.0% Higher Growth AVDL
Operating Margin (TTM) Profitability 2.5% 12.9% Higher Margin ALVO
Net Profit Margin Profitability -0.1% -50.6% Higher Margin AVDL
Return on Equity (ROE) Capital Efficiency -0.3% 0.0% Higher ROE ALVO
52-Week Range Position Momentum 89% ($6โ€“$24) 33% ($3โ€“$7) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 0.14ฮฒ ยท 2% Vol 0.73ฮฒ ยท 68% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 62.9 / 100 (BUY) 52.2 / 100 (HOLD) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AVDL vs ALVO Buy Guide
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ALVO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ALVO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AVDL nor ALVO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.